Your browser doesn't support javascript.
loading
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.
de Lima, Marcos; Porter, David L; Battiwalla, Minoo; Bishop, Michael R; Giralt, Sergio A; Hardy, Nancy M; Kröger, Nicolaus; Wayne, Alan S; Schmid, Christoph.
Afiliação
  • de Lima M; Hematologic Malignancies and Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio.
  • Porter DL; Blood and Marrow Transplantation, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Battiwalla M; Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland.
  • Bishop MR; Section of Hematology/Oncology, University of Chicago Medicine, Chicago, Illinois.
  • Giralt SA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Hardy NM; Experimental Transplantation Immunology Branch, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland. Electronic address: hardyn@mail.nih.gov.
  • Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wayne AS; Pediatric Oncology Branch, National Cancer Institute, Center for Cancer Research, Bethesda, Maryland; Current: Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Schmid C; Klinikum Augsburg, University of Munich, Munich, Germany.
Biol Blood Marrow Transplant ; 20(1): 4-13, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24018392

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Agonistas Mieloablativos / Efeito Enxerto vs Tumor / Antineoplásicos Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Agonistas Mieloablativos / Efeito Enxerto vs Tumor / Antineoplásicos Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2014 Tipo de documento: Article